- Clinical Development
- Therapeutic Expertise
- News & Resources
SynteractHCR’s oncology-focused teams have assisted clients with more than 450 oncology trials enrolling over 50,150 patients. Our in-depth therapeutic knowledge spans the entire clinical process, from the design and execution of proof of concept trials to regulatory approval.
We have a particular depth of expertise in early phase oncology research. Every project matters and is unique to us and thereby treated accordingly. In addition, we offer cost effective data management solutions particularly suited to smaller early phase oncology trials.
SynteractHCR also has nearly 10 years of experience in successfully leading immunotherapy trials, considerably more experience than many mid-sized CROs. Immunotherapy trials require special expertise and knowledge, due to the complexity of patient screening, procedural planning, treatment customization and regulatory requirements. Within cancer immunotherapy, we have experience in treatment approaches including check point inhibitors, combination therapy, oncolytic viruses, cancer vaccines with Dendritic cells, and cell therapy, among others.
Across our project management team, 85 percent have oncology experience, and our client medical advisor has nearly two decades of experience in all phases of oncology drug development, including global, clinical programs and national regulatory authorities. The strong relationships we’ve developed with experienced oncology investigative sites are also a critical component in supporting your mission to advance treatments in this critical area of research.
SynteractHCR has conducted
trials across all major
therapeutic areas and
we have contributed
to more than 230